Stock listing
NASDAQ:NTRP Neurotrope Inc Stock
Follow Neurotrope Inc into a list and get an email when it puts out news.
Last close · NASDAQ:NTRP
$0.941 USD
Close on Dec 2, 2020 · No longer trades
- Lowest – highest close
- $0.645 – $28.600 USDSince Jan 12, 2017 · lowest Oct 11, 2019 · highest Mar 13, 2017
Delisted NASDAQ:NTRP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NTRP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Latest news
Neurotrope Inc on 6ix
- News releases
- 21 in all · newest Dec 2, 2020 · oldest 2019
- Decks
- 4 decks · latest Jan 8, 2018
Events
- Next results
- Jan 13, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Oct 15, 2026 · After close | −18.6% |
| Quarter to Jun 30, 2026 | Jul 15, 2026 · After close | −18.6% |
| Quarter to Dec 31, 2025 | Jan 14, 2026 · After close | −11.7% |
| Quarter to Sep 30, 2025 | Oct 15, 2025 · After close | −12.6% |
| Quarter to Jun 30, 2025 | Jul 15, 2025 · After close | +3.0% |
| Quarter to Mar 31, 2025 | May 29, 2025 | +5.1% |
| Quarter to Dec 31, 2024 | Jan 14, 2025 · After close | −4.6% |
| Quarter to Sep 30, 2024 | Oct 15, 2024 · After close | +5.0% |
| Quarter to Jun 30, 2024 | Aug 31, 2024 | −10.0% |
| Quarter to Mar 31, 2024 | May 31, 2024 | −7.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2023 | Dec 28, 2023 · After close | −5.2% |
| Quarter to Jun 30, 2023 | Aug 15, 2023 | −8.5% |
| Quarter to Mar 31, 2023 | May 16, 2023 | −13.4% |
| Quarter to Sep 30, 2022 | Nov 14, 2022 | +2.5% |
| Quarter to Jun 30, 2022 | Aug 5, 2022 | −18.9% |
| Quarter to Mar 31, 2022 | Apr 27, 2022 | −25.3% |
| Quarter to Dec 31, 2021 | Mar 25, 2022 | −4.8% |
| Quarter to Sep 30, 2021 | Oct 22, 2021 | −7.5% |
| Quarter to Jun 30, 2021 | Aug 5, 2021 | +6.3% |
| Quarter to Mar 31, 2021 | May 17, 2021 | +3.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (January 2018) | Technical | 20 slides | Jan 8, 2018 |
| Investor Presentation (February 2016) | Investor deck | 35 slides | Feb 23, 2016 |
| Investor Presentation (January 2015) | Investor deck | 20 slides | Jan 14, 2015 |
| Investor Presentation (January 2014) | Investor deck | 22 slides | Jan 13, 2014 |
Cap table
Built by 6ix from Neurotrope Inc’s releases · as of Oct 14, 2026
- Common shares
- 15,229,900
- Fully diluted
- 15,229,900
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 15,229,900 | Oct 14, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 14, 2026 | 15,229,900 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joshua N. Silverman Other companies: Femasys Inc. (Director · Since at least Nov 21, 2023); PharmaCyte Biotech, Inc. (Interim Chief Executive Officer, President, and Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Executive Chairman · Since at least Jun 4, 2021); Petros Pharmaceuticals Inc (Vice-Chairman of the Board · Since at least Dec 1, 2020); Q/C Technologies, Inc. (Executive Chairman · Since at least Sep 6, 2018); Fabric.AI, Inc. (Chief Executive Officer, Director · Since at least Aug 15, 2016); Marker Therapeutics, Inc. (Director · Nov 28, 2016 – Oct 16, 2018 · Past); Protagenic Therapeutics, Inc. (Director · Feb 12, 2016 – Feb 21, 2020 · Past); MGT Capital Investments, Inc. (Director · Dec 31, 2015 – Dec 31, 2015 · Past); National Holdings Corporation (Director · Jul 28, 2014 – Sep 12, 2016 · Past) | Director · Aug 4, 2016 – Dec 1, 2020 · Past |
| Robert Weinstein Other companies: Petros Pharmaceuticals Inc (Chief Accounting Officer · Since at least Jun 18, 2026); PharmaCyte Biotech, Inc. (Director · Since at least Nov 14, 2022); TAO Synergies Inc. (Chief Financial Officer · Since at least Jun 4, 2021); XWELL, Inc. (Director & Chair of Audit Committee · Since at least Feb 3, 2020); TaoWeave, Inc. (Director · May 29, 2023 – May 29, 2023 · Past) | See Remarks · Nov 13, 2015 – Dec 1, 2020 · Past |
| Ivan P Gergel Other companies: Corium International Inc (Director · Dec 4, 2014 – Nov 27, 2018 · Past); Nektar Therapeutics (SVP & Chief Medical Officer · May 19, 2014 – Nov 15, 2017 · Past); Endo International PLC (EVP, R&D and CSO · Mar 10, 2014 – Mar 10, 2014 · Past) | Director · Dec 13, 2018 – Dec 1, 2020 · Past |
| Jonathan L. Schechter Other companies: TaoWeave, Inc. (Director · Since at least May 29, 2023); PharmaCyte Biotech, Inc. (Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Director · Since at least Jun 4, 2021) | Director · Mar 15, 2019 – Dec 1, 2020 · Past |
| Charles Ryan Other companies: Polaryx Therapeutics, Inc. (Director · Since at least Jan 29, 2026); Quince Therapeutics, Inc. (President · Since at least Sep 1, 2023) | Director · Nov 24, 2020 – Dec 1, 2020 · Past |
| Jay M Haft Other companies: Kingstone Companies, Inc (Director · Mar 31, 2008 – Jan 3, 2020 · Past); Moscow Cablecom Corp (Director · Jan 3, 2006 – Jul 19, 2007 · Past) | Director · Aug 29, 2014 – Nov 30, 2015 · Past |
| Daniel L Alkon Other companies: TAO Synergies Inc. (President and CSO, Director · Jun 4, 2021 – Dec 16, 2022 · Past) | See Remarks · Jan 22, 2019 – Dec 1, 2020 · Past |
| Michael Ciraolo | COO and General Counsel · Apr 1, 2019 – Apr 15, 2019 · Past |
| Paula T Trzepacz | See Remarks · Jun 15, 2016 – Jun 15, 2016 · Past |
Log in to ask 6ix AI your own questions about Neurotrope Inc.